Defining the Biology of the ADAR1-RISC Complex
- Institution
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY
- Principal investigator
- Benjamin R. Tenoever
- Funding
- $186K
- Duration
- 2022–2027
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY The means by which cells respond to virus infection is critical for survival. Moreover, the cellular response to virus differs dramatically depending on its position on the tree of life. This observation suggests that there are many successful strategies to inhibit virus infection, just as there are many viral antagonists that have evolved to interfere with them. Interestingly, while the cellular response to virus infection in mammals is primarily mediated by the family of Type I interferons (IFN-I), we recently characterized an IFN-I-independent defense system that involves an evolutionary conserved RNAse III nuclease. We find that this nuclease, called Drosha, rapidly translocates to the cytoplasm in response to virus infection and forms a high molecular weight structure by associating with the RNA-induced silencing complex (RISC) which we have termed the ADAR-RISC Complex or simply, ARC. Here we seek to better understand the physiological relevance of this complex.
LOADING MOONBASE SCORE
Questions for NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · New York University School of MedicineNot yet scored
Development and optimization of a peptide inhibitor of influenza virus splicing for broad-spectrum antiviral therapy
Benjamin R. Tenoever · $3.2M · 2025–2029
- NIH · New York University School of MedicineNot yet scored
Defining the Biology of the ADAR1-RISC Complex
Benjamin R. Tenoever · $697K · 2022–2027
- NIH · New York University School of Medicine68
EPITRANSCRIPTOMIC REGULATION OF CYTOMEGALOVIRUS INFECTION
Daniel Pearce Depledge · $529K · 2020–2026